Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-04 4:16 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | Kinnevik AB (publ) | 11,905,668 4.300% | 1,500,000 (+14.42%) | View |
2023-05-22 4:05 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | Kinnevik AB (publ) | 10,405,668 5.600% | 10,405,668 (New Position) | View |
2022-11-14 06:52 am Purchase | 13D | BABYLON HLDGS LTD BBLNF | Kinnevik AB (publ) | 115,433,522 18.600% | 60,490,954 (+110.10%) | View |
2022-05-25 2:30 pm Purchase | 13G | BABYLON HLDGS LTD BBLNF | Kinnevik AB (publ) | 54,942,568 16.600% | 54,942,568 (New Position) | View |
2022-02-08 2:13 pm Purchase | 13G | Kinnevik AB (publ) BBLN | Invik S.A. | 54,942,568 16.600% | 54,942,568 (New Position) | View |
2021-04-15 4:00 pm Unchanged | 13D | TELADOC HEALTH, INC. TDOC | Kinnevik AB (publ) | 7,491,124 4.910% | 0 (Unchanged) | View |
2020-12-21 4:00 pm Unchanged | 13D | TELADOC HEALTH, INC. TDOC | Kinnevik AB (publ) | 7,491,124 5.200% | 0 (Unchanged) | View |
2020-11-09 11:18 am Purchase | 13D | TELADOC HEALTH, INC. TDOC | Kinnevik AB (publ) | 7,491,124 5.200% | 7,491,124 (New Position) | View |
2020-11-03 3:04 pm Sale | 13D | LIVONGO HEALTH INC LVGO | Kinnevik AB (publ) | 0 0.000% | -12,653,927 (Position Closed) | View |
2020-01-21 2:54 pm Sale | 13G | MILLICOM INTERNATIONAL CELLULAR SA TIGO | Kinnevik AB (publ) | 0 0.000% | -37,835,438 (Position Closed) | View |